Development of Sleep medications MYTH-understanding (SMYTH) and Sleep Medications Overexpectation of REsponses (SMORE) among the general population
Sleep and Breathing · 2026-05 · 30 (2)
DOI: 10.1007/s11325-026-03699-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sleep and Breathing, online erschienen am 02.05.2026. Verfasst von Seockhoon Chung und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Asan Medical Center, University of Ulsan College of Medicine, 86 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Ko…. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Hypnotics and Sedatives. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: This study aimed to develop rating scales for assessing an individual's misconceptions and overexpectations regarding sleep medications. METHODS: An online survey was conducted among the general population in Korea. Scale items were generated and refined using exploratory factor analyses, and the final versions were validated using confirmatory factor analyses. Convergent validity was examined using the Insomnia Severity Index (ISI), Patient Health Questionnaire-2 (PHQ-2), Generalized Anxiety Disorder-7 (GAD-7), Dysfunctional Beliefs and Attitudes about Sleep-6 (DBAS-6), Glasgow Sleep Effort Scale (GSES), and sleep indices, including the two-item questionnaire version of the discrepancy between desired time in bed and desired total sleep time (DBSTq-2). RESULTS: Responses from 550 participants were analyzed. The two-factor model of the 10-item Sleep medications MYTH-understanding (SMYTH) scale demonstrated excellent model fit (comparative fit index [CFI] = 0.99, Tucker-Lewis index [TLI] = 0.99, root mean square error of approximation [RMSEA] = 0.019, and standardized root mean square residual [SRMR] = 0.054) and good reliability of internal consistency (McDonald's ω = 0.895). The SMYTH scale was significantly correlated with the DBSTq-2, GAD-7, DBAS-6, and GSES. Additionally, a single-factor model, the 10-item Sleep Medications Overexpectation of REsponses (SMORE) scale, was developed. The SMORE scale demonstrated excellent fit indices (CFI = 1.00, TLI = 1.00, RMSEA = 0.005, and SRMR = 0.059) and high reliability (McDonald's ω = 0.935). The SMORE scale was also significantly correlated with the DBSTq-2, ISI, PHQ-2, GAD-7, DBAS-6, and GSES. CONCLUSIONS: The SMYTH and SMORE scales are reliable and valid rating instruments for measuring misunderstandings and overexpectations related to sleep medications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Asan Medical Center, University of Ulsan College of Medicine, 86 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea. schung@amc.seoul.kr.
- Life Care Center for Cancer Patient, Asan Medical Center Cancer Institute, Asan Medical Center, Seoul, Korea. schung@amc.seoul.kr.
- School of Mathematics, Statistics and Data Science, Sungshin Women's University, 2, Bomun-ro 34da-gil, Seongbuk-gu, Seoul, 02844, Republic of Korea. alwaysns@sungshin.ac.kr.
Zitieren
APA
Chung, S., & Jeon, S. (2026). Development of Sleep medications MYTH-understanding (SMYTH) and Sleep Medications Overexpectation of REsponses (SMORE) among the general population. Sleep and Breathing, 30(2). https://doi.org/10.1007/s11325-026-03699-8
Vancouver
Chung S, Jeon S. Development of Sleep medications MYTH-understanding (SMYTH) and Sleep Medications Overexpectation of REsponses (SMORE) among the general population. Sleep and Breathing. 2026;30(2). doi:10.1007/s11325-026-03699-8
BibTeX
@article{Chung2026,
author = {Chung, Seockhoon and Jeon, Saebom},
title = {Development of Sleep medications MYTH-understanding (SMYTH) and Sleep Medications Overexpectation of REsponses (SMORE) among the general population},
journal = {Sleep and Breathing},
year = {2026},
volume = {30},
number = {2},
doi = {10.1007/s11325-026-03699-8}
}
EUVIMED